Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RiMO-301 |
Synonyms | |
Therapy Description |
RiMO-301 is a nanoparticle-based metal-organic framework that may enhance radiosensivity and activity of immunotherapy (PMID: 32607433, J Clin Oncol 2023 41:16_suppl, 2527). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RiMO-301 | RiMO301|RiMO 301 | RiMO-301 is a nanoparticle-based metal-organic framework that may enhance radiosensivity and activity of immunotherapy (PMID: 32607433, J Clin Oncol 2023 41:16_suppl, 2527). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03444714 | Phase I | RiMO-301 | Phase I Study of RiMO-301 With Radiation in Advanced Tumors | Recruiting | USA | 0 |